ONE Gas, Inc.
$7.73B- Market cap
- $5.02B
- Debt
- +$2.72B
- Cash
- −$9.68M
Capital structure 65% equity / 35% debt · EV / Revenue 3.00x · EV / EBITDA 17.81x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: OGS stock price vs AMRN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMRN's multiple
Needs AMRN P/E.
Implied fair value · at OGS's multiple
Needs EPS (TTM) is negative, OGS P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OGS FY 2022 (ended Dec 31, 2022) · AMRN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
13 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 65% equity / 35% debt · EV / Revenue 3.00x · EV / EBITDA 17.81x
Capital structure 97% equity / 3% debt · EV / Revenue 26.21x
OGS carries the larger enterprise value at $7.73B against $5.60B; OGS trades on the lower EV / Revenue multiple (3.00x vs 26.21x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ONE Gas, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
AMARIN CORP PLC\UK · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.05x
0.39x
Net debt / EBITDA
Leverage against operating earnings
6.24x
3.79x
Cash and equivalents
Liquid reserves on the balance sheet
$9.68M
$302.59M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ATMOS ENERGY CORP
OGS vs ATO
NEW JERSEY RESOURCES CORP
OGS vs NJR
Southwest Gas Holdings, Inc.
OGS vs SWX
Northwest Natural Holding Co
OGS vs NWN
LIGAND PHARMACEUTICALS INC
OGS vs LGND
Harmony Biosciences Holdings, Inc.
OGS vs HRMY
SUPERNUS PHARMACEUTICALS, INC.
OGS vs SUPN
Viatris Inc
OGS vs VTRS
Organon & Co.
OGS vs OGN
INCYTE CORP
OGS vs INCY
$2.72B
$177.39M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.